PESI
Information
Rising Resistance, Long-Acting Solutions: A Pharmacology Update for STI and HIV Management
Copyright :
Description
- Resistance is rising: Latest protocols for multidrug-resistant gonorrhea and Mycoplasma genitalium
- Implement injectables: Cabotegravir and twice-yearly lenacapavir to solve pill fatigue and modernize your PrEP practice
- Navigate the bicillin shortage, updated syphilis algorithms, and key guideline changes across chlamydia, gonorrhea, and PID
The clinical landscape for infectious diseases is moving faster than ever, and clinicians are experiencing a pivotal shift in how HIV and STIs are managed. This presentation isn't just a refresher; it’s a high-impact roadmap to mastering long-acting therapies. You will learn how to select and prescribe medications for STIs, confidently provide PrEP, and understand strategies for transitioning patients to new therapeutic options.
Gain the ability to implement the latest twice-yearly injectables, address drug shortages using imported alternatives, and apply new pharmacological approaches to combat "pill fatigue." You’ll be prepared to go beyond standard protocols, using targeted pharmacotherapy strategies.
Speakers
Audrey M. Stevenson, PhD, MPH, MSN, FNP-BC
Audrey M. Stevenson, PhD, MPH, MSN, FNP-BC, is a board-certified family nurse practitioner with over 45 years of experience spanning inpatient and ambulatory settings – including urgent care, community clinics, and STI clinics – as well as public health and healthcare leadership. She holds master’s degrees in both nursing and public health.
Dr. Stevenson has published and presented nationally and internationally on topics relevant to advanced practice nurses and other healthcare providers. She currently works as a consultant and teaches graduate FNP and MPH students at several universities. Her public health leadership includes serving as division director of family health and clinical services at the Salt Lake County Health Department and, during the COVID-19 pandemic, as vaccination branch director for the Salt Lake County Incident Command – where she oversaw vaccination strategies for 1.2 million residents.
Serving on the statewide vaccine advisory board, she has collaborated on vaccine policy and recommendations. She joined the National Foundation for Infectious Diseases Board of Directors in 2025 and participates in national workgroup focused on immunization strategies to improve vaccine uptake and reduce vaccine-preventable disease.
Speaker Disclosures:
Financial: Audrey Stevenson has employment relationships with the University of Utah and the University of Phoenix. She receives a speaking honorarium and consulting fee from Sequirus and Sanofi. She previously received a speaking honorarium from Merck and GSK. Audrey Stevenson receives a speaking honorarium and recording royalties PESI, Inc. All relevant financial relationships with ineligible organizations have been mitigated.
Non-financial: Audrey Stevenson is a member of the American Nurses Association and the American Association of Nurse Practitioners.
